![Harry Trout](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 205 985 $ in data 31/07/2026
Mr. Harry R.
Trout is a Chief Financial Officer at Enanta Pharmaceuticals, Inc. He received his undergraduate degree from Massachusetts College of Liberal Arts and an MBA from Southern New Hampshire University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 05/12/2025 | 16.348 ( 0,06% ) | 205 985 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ENANTA PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 26/08/2025 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Massachusetts College of Liberal Arts
 Massachusetts College of Liberal Arts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southern New Hampshire University
 Southern New Hampshire University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
